Apple Asks Judge to 'Follow the Majority Practice' in Dismissing Patent Dispute Over Night Vision Technology
"Courts, including in this district, have resoundingly rejected this approach, dismissing willful infringement claims where a complaint alleged that a defendant learned of the asserted patents solely through the filing of the complaint," attorneys with DLA Piper wrote on behalf of Apple's motion to dismiss a patent suit brought by SiOnyx over night vision technology.
'Nuclear Option'?: Eli Lilly Taps Big Law Firms in Federal Drug Pricing Dispute
The Health Resources and Services Administration has “invoked the nuclear option of removal from not only the 340B program but also Medicaid and Medicare Part B if manufacturers implement a cash replenishment model, counsel for Eli Lilly—the manufacturer of Mounjaro, Trulicity and other treatments for weight loss or diabetes—alleged in their complaint.